PHYLLIS DOWDEN: Open Payments
NPI 1497992598 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$196 in 11 payments from 8 companies in 2025. Trend: 2023 $15 · 2024 $0 · 2025 $196
Food & beverage: $196
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $50 |
| PFIZER INC. | 2 | $33 |
| ABBVIE INC. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Abbott Laboratories | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| SANOFI-AVENTIS U.S. LLC | 1 | $14 |
Products named: GEMTESA, ELIQUIS, QULIPTA, JARDIANCE, AREXVY, ETERNA, Symbravo, TZIELD.
Industry payments across GA — which companies pay providers there.
